Leptin assessment in acute lymphocytic leukemia survivors: Role of cranial radiotherapy?

Journal of Pediatric Hematology/Oncology

Volumn 29, Issue 11, 2007, Pages 776-782

  Siviero Miachon, Adriana Aparecida ^a   Spinola Castro, Angela Maria ^a,b   Tosta Hernandez, Patricia Debora Cavalcanti ^a   De Martino Lee, Maria Lucia ^a   Petrilli, Antonio Sergio ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Acute drug therapy; Acute radiotherapy and leukemia; Anthropometry; Body weight; Leptin; Leukemia; Lymphocytic

Indexed keywords

ASPARAGINASE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; LEPTIN; METHOTREXATE; VINCRISTINE;

ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CANCER RADIOTHERAPY; CANCER SURVIVOR; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUBERTY; SCHOOL CHILD; SCORING SYSTEM; SEX DIFFERENCE; SKULL IRRADIATION; STATISTICAL SIGNIFICANCE;

ADOLESCENT; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; CRANIAL IRRADIATION; FEMALE; HUMANS; LEPTIN; MALE; OBESITY; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 35948998099     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e318159a545     Document Type: Article

References (34)

1. Redaelli A, Laskin BL, Stephens JM, et al. A systematic literature review of the clinical and epidemiological burden of acute lymphoblastic leukaemia (ALL). Eur J Cancer Care (England). 2005;14:53-62.
2. Oeffinger KC, Eshelman DA, Tomlinson GE, et al. Providing primary care for long-term survivors of childhood acute lymphoblastic leukemia. J Fam Pract. 2000;49:1133-1146.
3. Campfield LA, Smith FJ, Guisez Y, et al. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science. 1995;269:546-549.
4. Argüelles B, Barrios V, Buño M, et al. Anthropometric parameters and their relationship to serum growth hormone-binding protein and leptin levels in children with acute lymphoblastic leukemia: a prospective study. Eur J Endocrinol. 2000;143:243-250.
5. Birkebaek NH, Fisker S, Clausen N, et al. Growth and endocrinological disorders up to 21 years after treatment for acute lymphoblastic leukemia in childhood. Med Pediatr Oncol. 1998;30:351-356.
6. Davies JH, Evans BAJ, Jones E, et al. Osteopenia, excess adiposity and hyperleptinaemia during 2 years of treatment for childhood acute lymphoblastic leukaemia without cranial irradiation. Clin Endocrinol (Oxford). 2004;60:358-365.
7. Oeffinger KC, Mertens AC, Sklar CA, et al. Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2003;21:1359-1365.
8. Nysom K, Holm K, Michaelsen KF, et al. Degree of fatness after treatment for acute lymphoblastic leukemia in childhood. J Clin Endocrinol Metab. 1999;84:4591-4596.
9. Sklar CA, Mertens AC, Walter A, et al. Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: role of cranial irradiation. Med Pediatr Oncol. 2000;35:91-95.
10. Shaw MP, Bath LE, Duff J, et al. Obesity in leukemia survivors: the familial contribution. Pediatr Hematol Oncol. 2000;17:231-237.
11. Didi M, Didcock E, Davies HA, et al. High incidence of obesity in young adults after treatment of acute lymphoblastic leukemia in childhood. J Pediatr. 1995;127:63-67.
12. Dalton VK, Rue M, Silverman LB, et al. Height and weight in children treated for acute lymphoblastic leukemia: relationship to CNS treatment. J Clin Oncol. 2003;21:2953-2960.
13. Birkebaek NH, Clausen N. Height and weight pattern up to 20 years after treatment for acute lymphoblastic leukaemia. Arch Dis Child. 1998;79:161-164.
14. Reilly JJ, Kelly A, Ness P, et al. Premature adiposity rebound in children treated for acute lymphoblastic leukemia. J Clin Endocrinol Metab. 2001;86:2775-2778.
15. Brennan BMD, Rahim A, Blum WF, et al. Hyperleptinaemia in young adults following cranial irradiation in childhood: growth hormone deficiency or leptin insensitivity? Clin Endocrinol (Oxford). 1999;50:163-169.
16. Adan L, Trivin C, Sainte-Rose C, et al. GH deficiency caused by cranial irradiation during childhood: factors and markers in young adults. J Clin Endocrinol Metab. 2001;86:5245-5251.
17. Mohnike K, Dörffel W, Timme J, et al. Final height and puberty in 40 patients after antileukaemic treatment during childhood. Eur J Pediatr. 1997;156:272-276.
18. Haddy TB, Mosher RB, Nunez SB, et al. Growth hormone deficiency after chemotherapy for acute lymphoblastic leukemia in children who have not received cranial radiation. Pediatr Blood Cancer. 2006;46:258-261.
19. Hino M, Nakao T, Yamane T, et al. Leptin receptor and leukemia. Leuk Lymphoma. 2000;36:457-461.
20. Brandalise S, Odone V, Pereira W, et al., All Brazilian Group. Treatment results of three consecutive Brazilian cooperative childhood ALL protocols: GBTLI-80, GBTLI-82 and -85. Leukemia. 1993;7(suppl 2):S142-S145.
21. National Center for Health Statistics (NCHS) [homepage on the Internet]. 2000 CDC Growth Charts: United States [updated July 21, 2006; cited November 08, 2006]. Available from: http://www.cdc.gov/growthcharts.
22. Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295:1549-1555.
23. Reilly JJ, Ventham JC, Newell J, et al. Risk factors for excess weight gain in children treated for acute lymphoblastic leukaemia. Int J Obes Relat Metab Disord. 2000;24:1537-1541.
24. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969;44:291-303.
25. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child. 1970;45:13-23.
26. Blum WF, Englaro P, Hanitsch S, et al. Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone. J Clin Endocrinol Metab. 1997;82:2904-2910.
27. Woods SC, Gotoh K, Clegg DJ. Gender differences in the control of energy homeostasis. Exp Biol Med (Maywood). 2003;228:1175-1180.
28. Garcia-Mayor RV, Andrade MA, Rios M, et al. Serum leptin levels in normal children: relationship to age, gender, body mass index, pituitary-gonadal hormones, and pubertal stage. J Clin Endocrinol Metab. 1997;82:2849-2855.
29. Brandão CMA, Lombardi MT, Nishida SK, et al. Serum leptin concentration during puberty in healthy nonobese adolescents. Braz J Med Biol Res. 2003;36:1293-1296.
30. Nagy TR, Gower BA, Trowbridge CA, et al. Effects of gender, ethnicity, body composition, and fat distribution on serum leptin concentrations in children. J Clin Endocrinol Metab. 1997;82:2148-2152.
31. Ross JA, Oeffinger KC, Davies SM, et al. Genetic variation in the leptin receptor gene and obesity in survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2004;22:3558-3562.
32. Oeffinger KC, Buchanan GR, Eshelman DA, et al. Cardiovascular risk factors in young adult survivors of childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2001;23:424-430.
33. Link K, Moëll C, Garwicz S, et al. Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood. J Clin Endocrinol Metab. 2004;89:5003-5012.
34. Kourti M, Tragiannidis A, Makedou A, et al. Metabolic syndrome in children and adolescents with acute lymphoblastic leukemia after the completion of chemotherapy. J Pediatr Hematol Oncol. 2005;27:499-501.